Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) was the target of a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 4,370,000 shares, a decline of 17.2% from the May 15th total of 5,280,000 shares. Approximately 28.2% of the company’s shares are short sold. Based on an average daily volume of 7,720,000 shares, the days-to-cover ratio is presently 0.6 days.
Institutional Trading of Aurora Cannabis
A number of hedge funds and other institutional investors have recently modified their holdings of ACB. MMCAP International Inc. SPC purchased a new stake in shares of Aurora Cannabis in the 3rd quarter worth about $4,659,000. Cambria Investment Management L.P. boosted its stake in Aurora Cannabis by 115.5% in the 3rd quarter. Cambria Investment Management L.P. now owns 386,365 shares of the company’s stock worth $226,000 after purchasing an additional 207,095 shares in the last quarter. Mackenzie Financial Corp bought a new position in Aurora Cannabis in the 4th quarter worth about $98,000. Virtu Financial LLC bought a new position in Aurora Cannabis in the 1st quarter worth about $727,000. Finally, Vanguard Personalized Indexing Management LLC bought a new position in Aurora Cannabis in the 4th quarter worth about $42,000. 47.63% of the stock is owned by hedge funds and other institutional investors.
Aurora Cannabis Stock Down 2.7 %
Shares of Aurora Cannabis stock opened at $5.74 on Friday. The company’s fifty day simple moving average is $6.59 and its two-hundred day simple moving average is $5.06. The company has a market cap of $313.12 million, a P/E ratio of -1.98 and a beta of 1.89. The company has a current ratio of 3.79, a quick ratio of 2.45 and a debt-to-equity ratio of 0.14. Aurora Cannabis has a 12-month low of $2.84 and a 12-month high of $11.50.
About Aurora Cannabis
(Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Stories
Before you consider Aurora Cannabis, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Aurora Cannabis wasn’t on the list.
While Aurora Cannabis currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Be the first to comment